28.4 C
Vientiane
Sunday, July 6, 2025
spot_img
Home Blog Page 242

ForwardX Deploys 435 AMRs at Chery Automobile’s Dalian Factory

Challenge Us to Move Your Parts — Solving Complex Automotive Intralogistics from Roof Systems to Car Doors

BEIJING, May 8, 2025 /PRNewswire/ — Tier 1 suppliers are under pressure to move more parts, more quickly, and with greater precision than ever before. As automotive manufacturing grows increasingly complex, intralogistics solutions must adapt to handle a wide range of components — from delicate electronics to heavy mechanical assemblies — across multiple workshops, in real time.

ForwardX Robotics is tackling this challenge head-on with one of the largest known deployments of autonomous mobile robots (AMRs) in automotive sector: 435 AMRs are now live at Chery’s Dalian factory, transforming internal logistics and setting a new benchmark for scalable, intelligent automation in the industry.

Tailored AMRs for Tier 1 Complexity

To meet the evolving needs of Tier 1 suppliers, ForwardX’s solution includes three specialized AMR models that work together to streamline movement across the entire factory floor:

  • Flex Series AMRs: Agile units ideal for transporting small, fragile components like circuit boards and wiring assemblies with just-in-time precision and minimal floor congestion.

Flex 300 carrying circuit boards
Flex 300 carrying circuit boards

  • Max Series AMRs: High-capacity robots designed to move heavy items such as engines and machinery parts, synchronizing seamlessly with production lines to eliminate delays.

Max O2500 carrying ultra large racks
Max O2500 carrying ultra large racks

  • Lynx U1000 Towing AMRs: Purpose-built for towing larger racks and bulky materials, fully integrated with Chery’s SPS system for autonomous delivery across key production zones.

Lynx Towing AMR fully integrated with Chery’s SPS system
Lynx Towing AMR fully integrated with Chery’s SPS system

“This deployment reflects our commitment to solving real production pain points at scale,” said Nicolas Chee, CEO of ForwardX Robotics. “Chery Automobile challenged us to streamline material flow in one of their most complex facilities — and with 435 AMRs working in harmony, we’re delivering a new era of intelligent intralogistics.”

Seamless Automation Across Multiple Workshops

The result? A synchronized flow of materials — large and small — across stamping, welding, battery, and final assembly workshops, with minimal disruption and maximum uptime. Chery’s factory can now support a vehicle rollout every two minutes, powered by autonomous logistics that adapt in real time.

Proven Across the Automotive Supply Chain

ForwardX’s technology has been successfully deployed at other leading manufacturers across Asia, highlighting its versatility across diverse workflows and factory environments:

  • At Inalfa, Max-1500L AMRs excel in constrained roof system workshops, moving heavy loads through tight paths with precision.
  • With BYD, Tailored Forklift AMRs featuring 2.4m forks automate material movement inside high-demand EV battery facilities, safely navigating hazardous spaces.
  • At Dongfeng Auto, Lynx U1000 AMRs handle car door transport inside the welding workshop, keeping pace with high-speed production lines.

These projects illustrate ForwardX’s strength in solving both general and highly specialized intralogistics challenges — from large rack movements to delicate component handling — all with flexible, scalable robotics that integrate into existing operations.

Meet ForwardX at Automate 2025 — Booth #5632

ForwardX is redefining what’s possible in automotive intralogistics. Whether you’re producing EVs, components, or complete vehicles, our AMRs are built to move your parts with speed, precision, and safety.

Join us at Automate 2025 in Booth #5632 to experience the future of automotive logistics.

NYSE Content Advisory: Pre-Market update + Aspen Insurance to debut on the NYSE

NEW YORK, May 8, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on May 8th

  • President Donald Trump is expected to unveil a trade pact today with the U.K. that would reduce the impact of some tariffs. The President announced a 10:00 AM ET press conference this morning in the Oval Office on Truth Social.
  • Federal Reserve Chair Jerome Powell noted increased uncertainty when he spoke to reporters yesterday following the latest interest rate decision. The central bank kept borrowing costs unchanged.
  • Aspen Insurance (NYSE: AHL) is set to debut on the NYSE today. It priced its upsized offering at $30 a share, which was within its target range. Aspen Insurance is a Bermuda based global provider of specialty insurance and reinsurance.

Opening Bell
Aspen Insurance Holdings Limited (NYSE: AHL) celebrates its listing on the NYSE

Closing Bell
Bradesco BBI (NYSE: BBD) celebrates its annual NYSE visit with top clients from Brazil

Watch NYSE TV Live every weekday 9:00-10:00am ET

Video – https://mma.prnewswire.com/media/2682653/NYSE_Market_Update_May_8.mp4

HTX and Justin Sun Launch $6M Mars Program Special Edition, Offering One User a Historic Space Journey

SINGAPORE, May 8, 2025 /PRNewswire/ — HTX, a leading global cryptocurrency exchange, has launched the Mars Program: Special Edition, a landmark campaign that will send one user on a $6 million space voyage, fully sponsored by Justin Sun, Advisor to HTX, and Founder of TRON.

The campaign runs from May 7, 08:00 to May 13, 04:00 (UTC). All users who completed Level 3 KYC verification on HTX are eligible to apply. Five new finalists will be selected based on registration date, trading activity, net fee contribution, and asset balance. They will join seven existing candidates, forming a group of 12, from which one winner will be chosen to embark on a space journey with Justin Sun in July 2025.

Campaign Details: https://www.htx.com.pk/support/25000906493178

A $6M Journey Beyond Earth

Justin Sun, one of the most prominent figures in the crypto industry, is personally funding the $6 million ticket for this mission. Known for his headline-making initiatives across Web3 and traditional finance, Sun aims to make space more accessible to the global crypto community.

“This mission isn’t about elites or executives—it’s about empowering users,” said Justin Sun. “Space exploration should be accessible. With this journey, we want to bring the crypto spirit beyond Earth’s limits.”

The Mars Program: Empowering Global Participation

HTX’s Mars Program has completed seven successful rounds, selecting seven individuals for potential space missions. The Special Edition marks a bold new chapter, opening participation to a broader group of users worldwide.

Rather than offering exclusive experiences to elites, HTX is extending a chance for everyday users to make history. The initiative reflects HTX’s vision of Web3 as an open, inclusive ecosystem—where breakthroughs in technology, finance, and culture converge.

Bridging Crypto and Cosmos

The Mars Program is more than a campaign—it’s a symbol of Web3’s potential to reshape real-world possibilities. HTX continues to explore how blockchain can extend beyond financial infrastructure and into personal dreams, collective imagination, and global narratives.

With this initiative, HTX positions itself at the forefront of innovation—not just in trading or technology, but in inspiring the next generation of crypto pioneers.

How to Participate

Users must complete Level 3 KYC on HTX and submit an application before the campaign ends. The winner, selected from 12 total finalists, will be announced ahead of the July 2025 launch.

About HTX

Founded in 2013, HTX has evolved from a virtual asset exchange into a comprehensive ecosystem of blockchain businesses that span digital asset trading, financial derivatives, research, investments, incubation, and other businesses.

As a world-leading gateway to Web3, HTX harbors global capabilities that enable it to provide users with safe and reliable services. Adhering to the growth strategy of “Global Expansion, Thriving Ecosystem, Wealth Effect, Security & Compliance,” HTX is dedicated to providing quality services and values to virtual asset enthusiasts worldwide.

To learn more about HTX, please visit HTX Square or https://www.htx.com/, and follow HTX on X, Telegram, and Discord.

TINECO INTRODUCES FLOOR ONE S7 STRETCH ULTRA: SMART FLOOR CLEANING WITH UNMATCHED FLEXIBILITY

Longer Runtime, Innovative DualBlock Anti-Tangle Design, and Enhanced Self-Cleaning Build on the Success of the Beloved Stretch S6

SEATTLE, May 8, 2025 /PRNewswire/ — Tineco, a global leader in intelligent home appliances, today announces the launch of the FLOOR ONE S7 Stretch Ultra, a next-generation smart floor washer that offers extended runtime, upgraded anti-tangle technology, and an optimized self-cleaning system. Building on the success of the FLOOR ONE Stretch S6, this new model is designed to deliver even more convenience and efficiency without compromising on the features users already love.

TINECO INTRODUCES FLOOR ONE S7 STRETCH ULTRA: SMART FLOOR CLEANING WITH UNMATCHED FLEXIBILITY
TINECO INTRODUCES FLOOR ONE S7 STRETCH ULTRA: SMART FLOOR CLEANING WITH UNMATCHED FLEXIBILITY

With a 180° Lay-Flat Design, the FLOOR ONE S7 Stretch Ultra maintains the hallmark reach and maneuverability of its predecessor while introducing an advanced DualBlock™ Anti-Tangle Design and a prolonged battery life to support longer, more efficient cleaning sessions. The enhanced FlashDry™ Self-Cleaning System also preserves the highly valued routine users rely on, now using 185°F heated water and hot air, up from the previous 153°F, for a deeper clean and superior drying.

Tineco’s intelligent iLoop™ Smart Sensor Technology continues to power real-time adjustments for suction and water flow, ensuring exceptional results with minimal effort. Additional key features of the FLOOR ONE S7 Stretch Ultra include:

  • Extended Runtime: Maximized battery life delivers up to 50 minutes of cleaning on a single charge.
  • DualBlock™ Anti-Tangle Design: A two-part scraper system with a front comb and straight edge captures and removes hair and debris, minimizing tangles and keeping the brush cleaner for longer.
  • 180° Flex Design: Stretches completely flat to reach under beds, couches, and tight spaces without moving heavy furniture.
  • All-in-One LED Display: Real-time feedback on performance, battery life, and cleaning status.
  • Dual Tank System: Keeps clean and dirty water separate for a consistently fresh clean.
  • Dual-sided Edge Cleaning: Glides closely along baseboards, ensuring that every corner is thoroughly cleaned.

The FLOOR ONE S7 Stretch Ultra is ideal for households seeking a smarter and more powerful cleaning solution, especially in homes with pets, children, or open floor plans that demand comprehensive and efficient maintenance.

The FLOOR ONE S7 Stretch Ultra is now available on the Tineco online store and  Amazon for $699. To learn more about Tineco and its full suite of floor care solutions, including vacuums, floor washers, and carpet cleaners, visit https://www.tineco.com.

About Tineco
Tineco was founded in 1998 with its first SKU as a vacuum cleaner and, in 2019, pioneered the first-ever smart vacuum. Today, the brand has innovated into a global leader offering intelligent appliances across home categories, including floor care, kitchen, and personal care. Tineco is dedicated to its brand vision of making life easier through smart technologies and consistently innovating new devices.

For more information, please visit https://www.tineco.com.

From Patient to Pioneer: jinIX Supports Nathan Ehrlich’s Mission for Rare Disease Research

SAN FRANCISCO, May 8, 2025 /PRNewswire/ — The jinIX Foundation hosted a meaningful and inspiring gathering—not just to mark the launch of its non-profit initiative, but to honor Nathan Ehrlich, a young rare disease advocate whose courage and vision are helping to reshape the future of patient-led clinical research.

jinIX Foundation, a nonprofit foundation, in collaboration with jinIX Cosmos Inc., develops digital health platform designed to improve the lives of rare disease patients. It offers an AI-powered symptom checker to help patients recognize early signs of rare diseases, and uses blockchain to keep medical data secure, private, and under the patient’s control. jinIX also builds tools to help patients share their data for research and connect with the right doctors and studies. Its mission is to make diagnosis faster, data more trustworthy, and clinical research more accessible to those who have been overlooked by traditional healthcare systems.

Diagnosed with leukemia at 16 and later found to carry a rare SAMD9L gene mutation, Nathan now lives with symptoms similar to Amyotrophic Lateral Sclerosis. For years, he faced uncertainty, fragmented care, and little hope for progress. But rather than give up, Nathan chose to fight—not only to uncover the root cause of his illness, but also to pursue a cure. He is not fighting just for himself, but for an entire community of patients like him.

To support this mission, Nathan founded the SAMD9L Foundation, a nonprofit dedicated to raising awareness, accelerating research, and building community for individuals and families affected by SAMD9L-related conditions.

At the event, Nathan shared his story publicly outlined his mission to launch a patient-led clinical trial, raise awareness for SAMD9L-related conditions, and build a global data and support network for others facing similar challenges.

“It takes a decade for an average rare disease patient to get a diagnosis. Most of us feel invisible,” Nathan said. “But with jinIX, something changed. They listened. They helped me turn my story into a study. Together, we’re not just searching for a cure—we’re building a movement.”

jinIX is working with the SAMD9L Foundation, which Nathan founded, to support a groundbreaking natural history study guided by Dr. David Putrino at Mount Sinai, NY. The project will collect electronic health journey data from patients with SAMD9L mutations and related conditions to better understand disease progression and treatment needs. jinIX’s role is to provide secure infrastructure, data management, and patient coordination for this work.

“This study is a new model for what patient-led, data-powered research can look like,” said Jeffrey Zhang, CEO of jinIX

Also in attendance was Patty DeDominic, a board member of the jinIX Foundation, founder of DeDominic & Associates, and a longtime advocate for women- and patient-led innovation:

“Nathan isn’t just a patient—he’s a pioneer,” Patty said. “jinIX exists to support visionaries like him, giving them the tools, technology, and partnerships to lead the way forward.”

The event closed with a performance of an original song, “The World Is Beautiful Because of Me,” composed to honor Nathan and the rare disease community. The gathering marked not just a launch, but a movement—one built on collaboration, compassion, and the belief that patient voices can guide meaningful change.

As jinIX continues to grow, it is expanding collaborations with researchers, physicians, and patient advocacy groups around the world. But its foundation will always be rooted in stories like Nathan’s—proof that real change begins when patients are trusted and empowered to lead.

To learn more about Nathan’s journey and support us, please visit https://www.samd9lfoundation.org/ or contact jinIX (www.jinix.io) via contact@jinix.io.

Hot Tech Innovators: ABI Research Names Globalstar, Iridium, and EchoStar MobileAmong 8 Top Satellite Operators Innovating in the IoT Market

NEW YORK, May 8, 2025 /PRNewswire/ — ABI Research, a global technology intelligence firm, awarded eight satellite operators a “Hot Tech Innovator” title for their contributions to the satellite IoT industry. Each awarded operator has been instrumental in maturing the satellite IoT ecosystem, creating new standards-based services or investing in large, IoT-compatible constellations to expand IoT customers’ options beyond terrestrial limits.

-

“Though it is ramping up, the satellite IoT market has developed a reputation of being out-of-step with IoT customers’ pricing and power requirements,” says Lizzie Stokes, Senior. Analyst at ABI Research. “Each of these Hot Tech Innovators is responsible for reversing that trend, bringing to market new technologies and service offerings that are both innovative and IoT-friendly.”

One Innovator, Globalstar, is known for its affordable IoT services. Its historical focus on one-way messaging in IoT-heavy markets, like asset tracking, has allowed the company to become an expert in low-cost, low-data communications. It will continue its accessible legacy by introducing a new two-way messaging offering. Globalstar’s accompanying LTE and 5G terrestrial spectrum for private networks is also an important differentiator, allowing the company to become a comprehensive connectivity provider. Iridium, another awarded Innovator, has focused its IoT innovation efforts around multi-mode capabilities, announcing in January 2024 its own 3GPP NTN service. This service will shake up the satellite IoT competitive landscape, as it competes directly with the 3GPP NTN services offered by two other Hot Tech Innovators, Sateliot and OQ Technology.

Though fairly new to the market, Sateliot and OQ Technology have been at the forefront of 3GPP NTN adoption, building LEO constellations based on the new standard. Both companies are forming cellular partnerships with influential MNOs and MVNOs to grow their platforms as their satellite infrastructure ramps up.

The LoRa NTN standard is also pertinent to satellites’ uptake in the IoT world, serving as an NTN technology that suits the IoT’s cost and power constraints. Hot Tech Innovators Lacuna Space and EchoStar Mobile are taking different paths to the standard’s adoption, with EchoStar Mobile primarily focusing on its pan-European LoRa NTN while Lacuna Space builds its constellation and expands into new markets.

Starlink is another influential player in the satellite IoT market, with plans to offer an IoT service in 2025. The company has an impressive mega-constellation of 6,791 LEO satellites as of October 2024. However, Starlink’s dominance could face competition from Amazon as it invests in its own satellite company, Amazon Project Kuiper. Amazon Project Kuiper also plans to use a huge constellation of LEO satellites to support a wide range of customer segments, from broadband services to IoT devices.

“A satellite operator’s success in the IoT market depends on various factors. The size of its constellation, its orbital regime, and its chosen protocols can affect how an operator appeals to an asset tracking or condition-based monitoring customer,” says Stokes. “Each operator listed in this report has displayed a thorough understanding of the IoT’s inherent constraints and prioritized offerings that will bring more IoT users into the non-terrestrial market.”

These findings are from ABI Research’s Hot Tech Innovators: Satellite IoT Platforms report. This report is part of the company’s IoT Networks and Platforms research service, which includes research, data, and ABI Insights.

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司,拥有得天独厚的优势,充当终端市场公司和技术解决方案提供商之间的桥梁,通过提供独家研究和专业性指导,推动成功的技术实施和提供经证明可吸引和留住客户的战略,无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info

Global
Deborah Petrara
Tel: +1.516.624.2558
pr@abiresearch.com

BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate

  • BioDlink congratulates Junshi Biosciences on receiving IND approval from China’s NMPA for JS212, the company’s first bispecific ADC.
  • JS212 combines dual-targeting antibody technology with a cytotoxic payload, representing a next-generation therapeutic.
  • BioDlink provided end-to-end development and manufacturing support, showcasing its industry-leading ADC capabilities.
  • Approval marks a key milestone in the development of next-generation antibody-drug conjugates.

SUZHOU, China, May 8, 2025 /PRNewswire/ — BioDlink, a leading global CDMO, proudly congratulates its partner Junshi Biosciences (HKEX-1877; SSE-688180), on receiving Investigational New Drug (IND) approval from the National Medical Products Administration (NMPA) of China to initiate clinical trials for the JS212 injection — Junshi Biosciences’ first bispecific antibody-drug conjugate (ADC).

JS212 represents a new class of bispecific ADCs that combine the humanized epidermal growth factor receptor and human epidermal growth factor receptor 3 bispecific antibody-drug conjugate to target both EGFR and HER3 — two proteins highly expressed in a variety of tumor cells, such as lung cancer, breast cancer, and head and neck cancer. As a bispecific ADC, JS212 has a key advantage over traditional ADCs that only target one protein: it can attack tumors via either EGFR or HER3, potentially increasing its effectiveness against a wider range of cancers and helping to overcome drug resistance.

Dr. Jun Liu, CEO and Executive Director of BioDlink, stated: “As a leader in ADC technology, BioDlink remains committed to technology innovation and one-stop solution platform for complex biologics. Our collaboration with Junshi Biosciences is built on mutual trust and deep experience in ADC research, development and manufacturing. The IND approval of JS212 — a technically demanding bispecific ADC —­ highlights our strong capabilities and strategic value we bring to partners pursuing next-generation biologics. We’re honored to support the advancement of this important program.”

Dr. Jing Tong, Deputy Director of Junshi Biosciences’ Innovation Research Institute, shared: “We are very pleased with the ongoing and highly productive partnership with BioDlink. Their exceptional expertise and proven capabilities in ADC development and manufacturing have played a pivotal role in advancing JS212 to this important milestone. Throughout the collaboration, BioDlink has consistently demonstrated technical excellence, operational efficiency, and a deep understanding of complex bispecific ADCs. This approval marks a key collaboration milestone, and we look forward to deepening our cooperation as we work toward bringing innovative therapies to patients in the future.”

BioDlink is committed to becoming a trusted CDMO biologics partner. The company operates a large-scale commercial biologics production site that meets international GMP standards and includes multiple integrated production lines for antibodies and ADCs.

With a comprehensive ADC platform supported by key R&D technologies, BioDlink enables efficient, centralized production of antibody intermediates, drug substances, and finished products. This setup accelerates timelines and reduces tech transfer costs. At the same time, BioDlink’s quality system is built according to international standards and has passed GMP audits in multiple countries, which can empower global customers.

About BioDlink Biopharm Co., Ltd.

With over 10 years of experience in antibody and ADC drug development, BioDlink offers full-service CDMO solutions for biologic drugs — from early-stage R&D through to commercial production.

The company has built integrated platforms for biologics and bioconjugates, offering process development, scale-up, and quality analytics solutions. Its scalable manufacturing lines include top-tier OEB-5 facilities for high-potency ADCs, with commercial antibody production already underway.

BioDlink’s quality management system complies with regulatory requirements in China, the U.S., the EU, and Japan. The company has successfully supported over 100 projects with development, clinical filings, and manufacturing services. In addition, the company has already passed near 100 GMP audits, including a zero-defect EU QP audit, with its quality systems earning worldwide recognition.

Guided by its “Empowering Innovation with Quality to Grow Together” mission, BioDlink is dedicated to enabling partners and advancing global healthcare through excellence in biologics.

About Shanghai Junshi Biosciences Co., Ltd.

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapeutics. The company has established a diversified R&D pipeline comprising over 50 drug candidates, with five therapeutic focus areas covering cancer, autoimmune, metabolic, neurological, and infectious diseases. Five of the company’s products have received approvals in China and international markets, one of which is toripalimab, China’s first domestically produced and independently developed anti-PD-1 monoclonal antibody. Toripalimab has been approved in over 35 countries and regions including China, the US, and Europe. During the COVID-19 pandemic, Junshi Biosciences actively shouldered the social responsibilities of a Chinese pharmaceutical company through its involvement in developing etesevimab, MINDEWEI®, and other novel therapies for the prevention and treatment of COVID-19.

With a mission of “providing patients with world-class, trustworthy, affordable, and innovative drugs,” Junshi Biosciences is “In China, For Global.” At present, the company boasts approximately 2,500 employees in the United States (Maryland) and China (Shanghai, Suzhou, Beijing, Guangzhou, etc.).

Yas Island Celebrates Announcement of Disney Theme Park Resort with a Record-Breaking Drone Show, Landmark Illuminations, Live Performances and Fireworks Spectacular

  • Over 9,000 drones lit up Yas Island’s sky in celebration of the landmark announcement of the Middle East’s first-ever Disney theme park resort destination
  • Global Celebrities – Tyrese Gibson, Naomi Campbell, Nancy Ajram, Chiara Ferragni, and Ed Westwick joined the celebrations on Wednesday May 7th on Yas Island
  • Guests were treated to a live performance featuring world-renowned pianist Lang Lang alongside beloved Emirati icon, Rashed Alnuaimi, Kerry Ellis and Sonya Balsara
  • Iconic UAE landmarks including Burj Khalifa and Aldar HQ lit up with dazzling visuals

Download show celebration video here
Download high-resolution images here

ABU DHABI, UAE, May 8, 2025 /PRNewswire/ — History was made last night as Miral and The Walt Disney Company celebrated the official announcement of the Middle East and Africa’s first-ever Disney theme park resort destination with a record breaking 9,000 drone show and fireworks spectacle. The show, which took place at Yas Links, also featured a live performance of world-renowned pianist Lang Lang alongside iconic Emirati singer Rashed Alnuaimi, queen of the West End, Kerry Ellis and classical sensation, Sonya Balsara.

Yas Island Celebrates Disney Theme Park Resort Show
Yas Island Celebrates Disney Theme Park Resort Show

This glittering celebration also attracted global celebrities including Tyrese Gibson, Naomi Campbell, Nancy Ajram, Chiara Ferragni, and Ed Westwick, dignitaries, entertainment industry leaders and media powerhouses, all converging to witness the unveiling of what promises to be a game-changing chapter in Disney’s legacy, and in the evolution of Yas Island as a global destination for entertainment.

Set against the stunning backdrop of Yas Island’s waterfront, the sky came alive with the largest drone light show ever staged in the region, symbolizing the spirit of imagination that defines both brands. This new destination project will be Disney’s seventh theme park resort worldwide and the first in the Middle East, connecting travelers from the Middle East to Africa, India, Asia, Europe, and beyond.

Celebrating the announcement, landmarks across the UAE, including Burj Khalifa and Aldar HQ came to life with a spectacular light show inspired by the magic of Disney. In Abu Dhabi, iconic buildings also lit up in blue, marking the start of an extraordinary chapter in entertainment and tourism.

The upcoming resort promises to seamlessly blend Disney’s legendary storytelling and attractions with Abu Dhabi’s vibrant culture, awe-inspiring shorelines, and iconic architecture. The new resort will be fully developed and built by Miral. Disney and its legendary Imagineers will lead creative design and operational oversight to provide a world-class experience.

The announcement celebration signals not only a major milestone for Miral and Disney but also reinforces Yas Island’s position as a global hub for entertainment, tourism, and leisure.

Details of the new resort will be revealed as the project progresses.

 

Yas Island Celebrates Disney Theme Park Resort Show
Yas Island Celebrates Disney Theme Park Resort Show

 

Yas Island Celebrates Disney Theme Park Resort Show
Yas Island Celebrates Disney Theme Park Resort Show